Selected article for: "gene type and innate immunity"

Author: McGuckin Wuertz, Kathryn; Treuting, Piper M.; Hemann, Emily A.; Esser-Nobis, Katharina; Snyder, Annelise G.; Graham, Jessica B.; Daniels, Brian P.; Wilkins, Courtney; Snyder, Jessica M.; Voss, Kathleen M.; Oberst, Andrew; Lund, Jennifer; Gale, Michael
Title: STING is required for host defense against neuropathological West Nile virus infection
  • Cord-id: h53zpjab
  • Document date: 2019_8_15
  • ID: h53zpjab
    Snippet: West Nile Virus (WNV), an emerging and re-emerging RNA virus, is the leading source of arboviral encephalitic morbidity and mortality in the United States. WNV infections are acutely controlled by innate immunity in peripheral tissues outside of the central nervous system (CNS) but WNV can evade the actions of interferon (IFN) to facilitate CNS invasion, causing encephalitis, encephalomyelitis, and death. Recent studies indicate that STimulator of INterferon Gene (STING), canonically known for i
    Document: West Nile Virus (WNV), an emerging and re-emerging RNA virus, is the leading source of arboviral encephalitic morbidity and mortality in the United States. WNV infections are acutely controlled by innate immunity in peripheral tissues outside of the central nervous system (CNS) but WNV can evade the actions of interferon (IFN) to facilitate CNS invasion, causing encephalitis, encephalomyelitis, and death. Recent studies indicate that STimulator of INterferon Gene (STING), canonically known for initiating a type I IFN production and innate immune response to cytosolic DNA, is required for host defense against neurotropic RNA viruses. We evaluated the role of STING in host defense to control WNV infection and pathology in a murine model of infection. When challenged with WNV, STING knock out (-/-) mice displayed increased morbidity and mortality compared to wild type (WT) mice. Virologic analysis and assessment of STING activation revealed that STING signaling was not required for control of WNV in the spleen nor was WNV sufficient to mediate canonical STING activation in vitro. However, STING-/- mice exhibited a clear trend of increased viral load and virus dissemination in the CNS. We found that STING-/- mice exhibited increased and prolonged neurological signs compared to WT mice. Pathological examination revealed increased lesions, mononuclear cellular infiltration and neuronal death in the CNS of STING-/- mice, with sustained pathology after viral clearance. We found that STING was required in bone marrow derived macrophages for early control of WNV replication and innate immune activation. In vivo, STING-/- mice developed an aberrant T cell response in both the spleen and brain during WNV infection that linked with increased and sustained CNS pathology compared to WT mice. Our findings demonstrate that STING plays a critical role in immune programming for the control of neurotropic WNV infection and CNS disease.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • absence presence and adaptive immune response: 1, 2
    • absence presence and adaptive immune response innate: 1
    • absence presence and adaptive response: 1, 2, 3
    • absence presence and lung model: 1, 2, 3, 4, 5, 6, 7
    • absence presence and lymph node: 1, 2, 3, 4, 5
    • absence presence and lysis buffer: 1, 2, 3, 4, 5
    • absence presence and m1 phenotype: 1
    • absolute number and acute infection: 1, 2, 3, 4, 5, 6, 7
    • absolute number and lymphocyte decrease number: 1, 2
    • acute infection and adaptive immune interface: 1
    • acute infection and adaptive immune interface innate: 1
    • acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • acute infection and adaptive immune response innate: 1, 2, 3, 4, 5, 6, 7, 8
    • acute infection and adaptive response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
    • acute infection and adaptor protein: 1, 2, 3
    • acute infection and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute infection and lysis buffer: 1
    • acute infection and m1 phenotype: 1, 2